- Home
- Products
FIRAZYR (Icatibant)
FIRAZYR (Icatibant)
- Medicine Name: FIRAZYR
- Generic Name: Icatibant
- Dosage Form & Strength: Subcutaneous injection 10 mg/mL
- Manufactured By: Shire Orphan Therapies, Inc.
FIRAZYR (Icatibant) is a bradykinin B2 receptor antagonist used for the treatment of acute attacks of hereditary angioedema (HAE) in adults aged 18 years and older.
It works by blocking the effects of bradykinin, a substance in the body that contributes to the swelling seen in HAE.
FDA Approval: FIRAZYR was approved by the U.S. FDA in 2011.
FIRAZYR should be administered only under the supervision of a healthcare provider familiar with HAE treatment.
Injection site reactions (such as redness, swelling, or discomfort) are the most commonly reported adverse effects.
Use with caution in patients with cardiovascular disease, especially those on medications affecting bradykinin metabolism.
Hypersensitivity reactions are rare but possible. Patients should be monitored for signs such as rash, itching, or breathing difficulty.
Not recommended for pediatric use. Safety and efficacy in children have not been established.
To legally import FIRAZYR (Icatibant) into India through Global Rare Meds, the following documentation is required:
Required Documentation:
- Valid prescription from a licensed medical specialist (immunologist or geneticist preferred)
- Diagnostic reports confirming Hereditary Angioedema (HAE)
- Government-issued patient ID
- Import permit (if applicable)
Availability in India:
FIRAZYR is not readily available in Indian retail pharmacies and must be imported on a named-patient basis. Global Rare Meds enables this service in cities like Mumbai, Delhi, Chennai, Bengaluru, Hyderabad, Kolkata, Ahmedabad, Pune, and more.
📧 Email: info@globalraremeds.com
📞 Call / WhatsApp: +91-99675 15602
Global Rare Meds sources FIRAZYR (Icatibant) from verified international suppliers to ensure authenticity and timely access:
- Imported from authorized sources in Europe, USA, Canada, and Australia
- Dispensed strictly against valid prescriptions by licensed pharmacists
- Dispatched securely from our fulfillment facility in Ambernath, Thane District
- End-to-end delivery and support available across India and internationally
Â
Q1: What is the generic name of FIRAZYR?
A: The generic name is Icatibant.
Q2: Who manufactures FIRAZYR?
A: FIRAZYR is manufactured by Shire Orphan Therapies, Inc.
Q3: What is FIRAZYR used for?
A: FIRAZYR is used to treat acute attacks of hereditary angioedema (HAE) in adults.
Q4: How is FIRAZYR administered?
A: It is supplied as a subcutaneous injection, with each prefilled syringe containing 10 mg of Icatibant per mL.
Q5: Is FIRAZYR approved by the FDA?
A: Yes, FIRAZYR was approved in 2011 by the U.S. FDA.
Q6: What are common side effects?
A: Most commonly reported effects are injection site reactions, including redness, swelling, and itching. Other possible side effects include nausea, headache, dizziness, and fever.
Q7: How much does FIRAZYR cost in India?
A: The price of FIRAZYR varies depending on the country of origin and shipping logistics. For a detailed quote, contact +91-99675 15602 or email info@globalraremeds.com
Q8: How should FIRAZYR be stored?
A: Store FIRAZYR at controlled room temperature (20°C to 25°C). Do not freeze. Protect from light and keep in original packaging until use.
Q9: Is it safe to order FIRAZYR online in India?
A: Yes. Global Rare Meds ensures legally compliant and authenticated delivery of FIRAZYR for patients across India with proper prescription and documentation.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
